In Vitro Evaluation of the Peptide Deformylase Inhibitor LBM415 in Combination with Aztreonam to Determine the Synergistic Potential Against Gram-positive and Gram-negative Pathogens
In Vitro Evaluation of the Peptide Deformylase Inhibitor LBM415 in Combination with Aztreonam to Determine the Synergistic Potential Against Gram-positive and Gram-negative Pathogens, Lead author: Biedenbach DJ, presented at 15th annual European Congress of Clinical Microbiology and Infectious Diseases (ECCMID), April 2 – 5, 2005, Copenhagen, Denmark
